Theresa's Biotech / Biomedical Blog April 2007 Archive

Scientists are about to begin clinical testing of a new anti-AIDs drug developed in Shanghai, China. The orally-administered drug works by inhibiting a cellular surface protein known as CCR5 which ... Read More

This years BIO International Convention, held May 6-9, 2007 is entitled “New Ideas. Bold Ventures. Global Benefits.” and will be held in Boston MA. The convention will feature three very ... Read More

Lately I’ve been noticing frequent references to nanoparticles, in cosmetics and beauty advertising. This week, while browsing through a popular home and fashion magazine, I was surprised to find a ... Read More

It's the time of year when there always seems to be a burst of activity on the Biotech conference scene. I've added some new links to biotech associations and related ... Read More

A new bill working its way through the California Legislature carries a proposal that all food derived from cloned animals and their progeny be labelled as such. The intent of ... Read More

In the biotech industry, intellectual property (IP) is an intangible asset which presents complications when it comes time to assign values. A new biotech startup with little or no assets, ... Read More

As I contemplated what is going on in the world today, Easter Sunday, and how I could relate it to my Biotech page, I wandered out into the living room ... Read More

Using the groundwork laid by the inventors of PCR technology and basic DNA sequencing methods, scientists working in biotechnology continue to develop additional new strategies for advanced genetic research. The ... Read More